tirzepatide lawsuits The Outsourcing Facilities Association (OFA) is suing the FDA after the agency removed (Zepbound, Mounjaro) from the federal drug shortage list without proper notice. The lawsuit claims that the FDA failed Mounjaro Lawsuit - July 2026

Both medications belong to a class of drugs that help control blood sugar and promote weight loss

GLP-1 injection pen isolated on clean background, medical syringe device for diabetes and weight loss treatment with copy space Captions are provided by our contributors

A 2026 JMIR mixed-methods analysis of 60 thematically-saturated Drugs.com reviews captured the bimodal split exactly: one reviewer wrote "I've been taking Ozempic for almost 1 year and I have lost 55 lbs," while another simply said "It has done absolutely NOTHING for me for weight loss." Aggregate Ratings: What 4,000+ Reviews Add Up To Pull every public review platform together and the average lands in the "useful but not magical" zone

Mounjaro is a dual GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-like Peptide-1) receptor agonist that mimics the effects of these naturally occurring gut hormones

Table of Contents: What disease can be treated with IV therapy

Why Choose GLP-1s for Weight Loss in Morristown, NJ